Today: 29 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

XRP price tumbles to $1.73 as Fed-chair uncertainty shakes crypto — what to watch next

XRP price tumbles to $1.73 as Fed-chair uncertainty shakes crypto — what to watch next

XRP fell 4.2% to $1.73 in the past 24 hours, extending its weekly loss to nearly 10% as crypto markets sold off on Fed policy uncertainty and tech sector weakness. Bitcoin dropped 2.5% to $82,300, while ether lost 2.9%. The Ninth Circuit upheld dismissal of a proposed investor class action against Ripple Labs. Microsoft shares slid 10% after reporting heavy AI-related spending.
Dow Jones today: 179-point drop on Fed-chair shakeup, hot PPI — what investors watch next

Dow Jones today: 179-point drop on Fed-chair shakeup, hot PPI — what investors watch next

The Dow fell 179.09 points to 48,892.47 after Donald Trump named Kevin Warsh as his pick for Federal Reserve chair and December producer prices rose 0.5%. The S&P 500 lost 0.43% and the Nasdaq dropped 0.94%. Microsoft shares slid 10% on disappointing cloud revenue, while Apple beat forecasts. The Warsh nomination moves to the Senate as the Fed holds rates steady.
Amazon stock slips after hours as layoffs and store exits sharpen focus on Feb. 5 earnings

Amazon stock slips after hours as layoffs and store exits sharpen focus on Feb. 5 earnings

Amazon shares fell about 1% in after-hours trading Friday, closing at $239.30. The company confirmed 16,000 corporate job cuts this week and announced closures of Amazon Fresh and Amazon Go stores. Investors are awaiting fourth-quarter results on Feb. 5 for updates on AWS demand and spending. AWS also reported network issues Thursday affecting some services in its US-East-1 region.
Broadcom stock price holds near $331 after Wolfe upgrade; AVGO eyes Google TPU demand

Broadcom stock price holds near $331 after Wolfe upgrade; AVGO eyes Google TPU demand

Broadcom shares closed at $331.30 Friday, up 0.2%, and held steady after hours following Wolfe Research’s upgrade to Outperform with a $400 price target. Wolfe cited rising demand for tensor processing units and Broadcom’s edge in AI chips. Options activity turned more bullish ahead of next week’s U.S. jobs report. Broadcom traded 28 million shares, swinging between $322.77 and $338.17 during the session.
Bezos’ Blue Origin pauses New Shepard space tourism flights for at least two years

Bezos’ Blue Origin pauses New Shepard space tourism flights for at least two years

Blue Origin will pause New Shepard space tourism flights for at least two years as it shifts focus to developing a lunar lander for NASA. The company has completed 38 New Shepard flights with 98 passengers since 2021. Blue Origin did not specify when flights will resume or how the pause affects existing customers. The move comes as NASA increases reliance on private contractors for lunar missions.
30 January 2026
Micron stock price drops nearly 5% after hours as Fed jitters hit MU shares

Micron stock price drops nearly 5% after hours as Fed jitters hit MU shares

Micron Technology shares fell 4.8% to $414.83 in after-hours trading Friday, following Trump’s nomination of Kevin Warsh for Fed chair and a high inflation reading. Apple warned rising memory-chip prices are pressuring profits, with Samsung forecasting a continued shortage. Micron began building a $24 billion wafer plant in Singapore, with output expected in 2028. About 49.3 million shares traded.
Microsoft stock extends post-earnings slide as AI spending debate heats up

Microsoft stock extends post-earnings slide as AI spending debate heats up

Microsoft shares fell 0.9% to $429.73 Friday, extending a sharp selloff that erased over $350 billion in value after disappointing cloud and spending updates. The company reported $81.3 billion in quarterly revenue and a 66% jump in capital spending, with two-thirds spent on chips. Microsoft also announced a $750 million, three-year AI deal with Perplexity AI to run on Azure.
Apple stock heads into next week with one big question: can AAPL dodge the memory-chip crunch?

Apple stock heads into next week with one big question: can AAPL dodge the memory-chip crunch?

Apple shares rose 0.6% to $259.92 in late Friday trading after the company projected fiscal Q2 revenue growth of 13–16%, beating analyst estimates. CEO Tim Cook cited strong iPhone demand but warned of processor supply issues and a global DRAM shortage expected to pressure margins. Apple reported quarterly revenue of $143.8 billion and EPS of $2.84. The company also acquired audio AI startup Q.ai for about $1.6 billion.
Sandisk stock price jumps after AI-fueled outlook; Kioxia deal and analyst calls in focus

Sandisk stock price jumps after AI-fueled outlook; Kioxia deal and analyst calls in focus

Sandisk shares rose 4.9% to $565.99 Friday after the company forecast Q3 revenue of $4.4–$4.8 billion and adjusted EPS of $12–$14, beating analyst estimates. Fiscal Q2 revenue climbed 31% to $3.03 billion, with gross margin at 50.9%. Sandisk and Kioxia extended their Japan joint venture through 2034, with Sandisk set to pay $1.165 billion between 2026 and 2029.
Tesla stock jumps on SpaceX-xAI merger talk as Elon Musk consolidation buzz grows

Tesla stock jumps on SpaceX-xAI merger talk as Elon Musk consolidation buzz grows

Tesla shares climbed 4% after reports that SpaceX is in talks to merge with xAI and may also consider a tie-up with Tesla, according to Bloomberg. The move follows Tesla’s announcement of over $20 billion in 2026 capital spending focused on autonomy and robotics. U.S. stocks broadly fell after Trump named Kevin Warsh as his Fed pick and producer prices rose more than expected. No merger agreement has been finalized.
ConocoPhillips stock rises as oil holds near six-month highs — what investors watch next

ConocoPhillips stock rises as oil holds near six-month highs — what investors watch next

ConocoPhillips shares rose 0.9% to $103.74 in Friday afternoon trading, tracking crude prices near six-month highs ahead of Sunday’s OPEC+ meeting. Investors are watching for the company’s fourth-quarter earnings call on Feb. 5. ConocoPhillips’ Alaska operations faced no expected long-term production change after a drilling rig accident. Brent settled at $70.69 a barrel, with OPEC+ expected to hold output steady.
30 January 2026
1 223 224 225 226 227 762

Stock Market Today

  • TSX Penny Stocks Under CA$500M: 3 Promising Picks for Investors
    April 29, 2026, 9:38 AM EDT. Investors eyeing TSX penny stocks with market caps under CA$500 million may find opportunities amid economic uncertainties. Top picks include Westbridge Renewable Energy (CA$41.02M), Cannara Biotech (CA$175.83M), and Zoomd Technologies (CA$93.74M), each backed by strong financial health ratings. Additionally, Nova Leap Health Corp. (CA$34.05M) offers potential with a new Palliative Care division, despite recent losses but maintains a strong cash runway. Meanwhile, Regulus Resources Inc. (CA$498.41M) operates in mineral exploration, debt-free but pre-revenue. These stocks may appeal to risk-tolerant investors seeking growth in smaller, financially resilient firms on the Canadian market.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop